biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD still can't admit it

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Nov 11, 2023 12:12pm

112 Views

Post# 35730193

RE:RE:RE:RE:RE:RE:RE:JD still can't admit it

Boomskid wrote: You'll have a hard time convincing anybody of that stuff, TT.

Funny, though.

ok, I'm done.

Bye bye TT. Catch you in the funny papers.

You'll have a hard time convincing anybody of that stuff

Says Johnny boy who has been wrong the past 12 years about Bioasis!

Says Johnny boy who thinks he is smarter than everyone (even Oncologists with their Masters/PHds) because only he "could connect the dots"!

Says the bankrupt fool, but I wiil have a hard time convincing people I am intelligent?

LMFAO!

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market